AMICUS THERAPEUTICS, INC. — Director's Dealing 2023

Jan 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2023-01-11

Reporting Person: Rosenberg Ellen (Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-11	Common Stock	A	56024	$0.00	Acquired	388369	Direct
2023-01-11	Common Stock	F	24185	$12.02	Disposed	364184	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15000	Indirect

Footnotes

F1: Granted for the achievement of the 2020 PRSU TSR goal as determined by the Compensation and Leadership Development Committee of the Board of Directors.